Eschenbach Andrew C. Von

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
10 years
Director since
2023

10 years of board service in total across 3 boards, counting each seat separately. Longest: Bausch + Lomb Corporation, 3 years.

3 years · Since 2023
Celularity Inc. Director
3 years · Since 2023
3 years · Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 7, 2026 Bausch + Lomb Corporation Open-market sale −6,059 $16.58 $100,458
Aug 6, 2026 Bausch + Lomb Corporation Open-market sale −12,500 $16.50 $206,250
May 26, 2026 Bausch + Lomb Corporation Grant or award +15,842 $15.78 $249,987
Feb 27, 2026 Bausch + Lomb Corporation Open-market purchase +4,364 $18.31 $79,905
Feb 27, 2026 Bausch + Lomb Corporation Grant or award +4,364 — —
May 27, 2025 Bausch + Lomb Corporation Grant or award +20,338 — —
May 2, 2025 Bausch + Lomb Corporation Open-market purchase +1,695 $11.76 $19,933
Aug 2, 2024 Bausch + Lomb Corporation Grant or award +14,696 — —
Jun 14, 2023 Celularity Inc. Grant or award +199,921 — —
May 4, 2023 Bausch + Lomb Corporation Grant or award +12,857 — —

Questions about Eschenbach Andrew C. Von

What boards is Eschenbach Andrew C. Von on?

Eschenbach Andrew C. Von sits on the boards of Bausch + Lomb Corporation, Celularity Inc. and TriSalus Life Sciences Inc.

How long has Eschenbach Andrew C. Von served on boards?

Our records show at least 10 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.